CIK THERAPY AT CHINESE HOSPITALS:
A GUIDE FOR INTERNATIONAL PATIENTS
Everything international patients need to know about accessing CIK therapy at Chinese academic cancer centres โ from choosing the right hospital and obtaining a medical visa to what happens at each stage of your stay.
analyticsAt a Glance
- check_circleChina has the world's largest concentration of GMP-certified CIK centres with dedicated international patient programmes
- check_circleMajor academic cancer hospitals in Beijing, Shanghai, Guangzhou, and Zhengzhou lead in CIK clinical experience
- check_circleMedical visas for cancer treatment are routinely issued โ typically within 5โ7 working days of a hospital invitation letter
- check_circleCancerFax coordinates the entire process โ from medical record review to post-treatment follow-up
Why China for CIK Therapy?
China is not simply one option for CIK therapy โ it is the global centre of CIK clinical expertise. The therapy was developed and refined primarily at Chinese academic cancer centres over two decades, producing the world's largest evidence base. The GMP manufacturing infrastructure, specialist clinical teams, and regulatory framework for CIK therapy are more mature in China than anywhere else in the world.
โGoing to China for CIK therapy is not medical tourism โ it is going to where the clinical expertise actually lives.โ
Largest Evidence Base
Over 100 randomised controlled trials of CIK therapy have been conducted at Chinese academic cancer centres. The treating oncologists at these institutions have hands-on experience with hundreds or thousands of CIK patients โ a clinical depth unavailable elsewhere.
GMP Infrastructure at Scale
Major Chinese cancer centres operate ISO-certified, NMPA-inspected GMP cell therapy manufacturing facilities producing CIK cells to the same quality standards required of pharmaceutical products โ not informal laboratory procedures.
International Patient Programmes
Tier-1 Chinese cancer centres maintain dedicated international patient departments with English-speaking coordinators, medical visa invitation letter services, airport transfer arrangements, and interpreter support โ making access practical for non-Chinese-speaking patients.
Cost Advantage
CIK therapy in China costs a fraction of equivalent cell therapies in the USA or Europe โ while being delivered at facilities with internationally comparable GMP standards. This makes treatment accessible to patients priced out of Western markets.
The International Patient Journey: Step by Step
From first contact with CancerFax to completing your CIK therapy programme in China โ a clear walkthrough of every stage of the process.
- 1
Submit Medical Records to CancerFax
Upload or email your pathology reports, imaging (CT/MRI/PET-CT), treatment history, blood tests, and surgeon/oncologist referral letters. Records in any language are accepted.
- 2
CancerFax Clinical Review and Centre Matching
Our clinical team reviews your case, confirms CIK eligibility, identifies the most appropriate specialist centre based on your cancer type and treatment context, and prepares a structured oncology summary for the Chinese oncology team.
- 3
Hospital Consultation and Cost Estimate
CancerFax submits your oncology summary to the chosen centre. The treating oncologist reviews the case and provides an initial consultation (remote or in-person), formal eligibility confirmation, and written treatment cost estimate.
- 4
Medical Visa and Travel Preparation
CancerFax arranges the medical visa invitation letter from the hospital. You apply for a Chinese medical visa at your nearest Chinese embassy or consulate โ typically processed in 5โ10 working days. Flight and accommodation are arranged in parallel.
- 5
Arrival and Blood Collection
On or shortly after arrival, the hospital performs a pre-treatment assessment (physical examination, blood tests, imaging review) and conducts the leukapheresis or blood draw for CIK manufacturing. Manufacturing begins immediately.
- 6
Manufacturing Period (14โ21 Days)
While CIK cells are being manufactured and quality-tested, patients can rest locally or undertake preliminary consultation appointments with the oncology team. CancerFax remains in daily contact with the hospital coordination team.
- 7
CIK Infusion Cycles
Upon manufacturing completion and QC release, CIK infusions are administered in the hospital's day-ward โ typically 3โ5 consecutive daily infusions per cycle. Most patients complete the first cycle and then return home, with subsequent cycles coordinated for future visits.
- 8
Post-Treatment Follow-Up
CancerFax coordinates the translation of your discharge summary and treatment reports for your home oncologist, and assists with scheduling subsequent CIK cycles and remote follow-up assessments from the Chinese centre.
Choosing a Chinese Hospital for CIK Therapy โ What to Look For
Not all Chinese hospitals offering CIK therapy operate to the same standard. These criteria help patients and families distinguish specialist centres from those offering lower-quality programmes.
| Criterion | What to Look For | Red Flag |
|---|---|---|
| GMP Manufacturing Certification | NMPA-inspected GMP cell therapy facility on-site or affiliated | No GMP certification disclosed โ cells may be produced in standard labs |
| Published CIK Clinical Experience | Published RCT or cohort data from this centre or affiliated department | No published clinical data and no ongoing registered trials |
| International Patient Department | Dedicated English-speaking coordinator, medical visa letter service, interpreter | No established international patient pathway โ all communication in Mandarin only |
| Quality Control Transparency | Written QC report provided to patient (viability, sterility, phenotype) before each infusion | No QC documentation offered or available |
| Tumour Board Review | Cases reviewed by multidisciplinary oncology team before CIK protocol is confirmed | Single-physician decisions with no MDT process |
| Post-Treatment Report | Structured discharge summary in English with treatment details for home oncologist | No translated clinical documentation provided after treatment |
Preparing for Your Trip to China โ Do and Don't
Practical preparation guidance for international patients planning CIK therapy in China โ what to organise in advance, and what mistakes to avoid.
Do Before You Travel
- Obtain a complete set of medical records in EnglishPathology report, latest imaging (with digital copy if possible), treatment summaries, and current medication list โ translated into English before departure.
- Apply for a Chinese medical visa with the hospital invitation letterRequest the formal invitation letter from CancerFax / the hospital as early as possible โ visa processing takes 5โ10 working days in most countries.
- Arrange travel insurance covering medical repatriationStandard travel insurance may not cover medical events abroad โ confirm your policy covers medical treatment, repatriation, and trip cancellation for medical reasons.
- Budget for the full stay including manufacturing wait timePlan to be in China for a minimum of 3โ4 weeks for the first cycle โ blood collection, manufacturing (14โ21 days), and infusions require sustained time in-country.
Don't
- Don't travel without written eligibility confirmation and a cost estimateArriving without confirmed eligibility and a written treatment plan puts you at risk of unexpected costs, delays, or inappropriate treatment decisions.
- Don't use unverified agents or intermediaries without GMP confirmationAgents who cannot provide GMP certification details for the manufacturing facility they work with are a serious quality risk.
- Don't assume all Chinese CIK providers are equivalentQuality varies enormously โ tier-1 academic cancer centres are categorically different from private clinics offering CIK without a published clinical programme.
- Don't stop prescribed medications without specialist guidanceStopping ongoing cancer medications before CIK therapy must be directed by the treating oncologist โ never self-managed based on general advice.
CancerFax Patient Support โ Available in Multiple Languages
CancerFax supports international patients in their own language throughout the entire CIK therapy coordination process โ from first contact to post-treatment follow-up.
- English
- Chinese (Mandarin)
- Arabic
- Hindi
- Bengali
- Russian
- French
More from the CIK Cell Therapy Resource Library
Complete your CIK therapy research โ from cost and eligibility to disease-specific evidence and combination approaches.
- CIK Cell Therapy โ Complete Treatment Guide
- Cost of CIK Therapy in China: A Complete Breakdown
- Patient Selection for CIK Therapy: Who Is a Good Candidate?
- Side Effects of CIK Therapy: What Patients Experience
- What Is CIK Therapy? A Complete Patient Introduction
- CIK Therapy After Cancer Surgery: Adjuvant Immune Support
Frequently Asked Questions: CIK Therapy in China for International Patients
Do I need to speak Mandarin to receive CIK therapy in China?
No. Tier-1 Chinese academic cancer centres have dedicated international patient departments with English-speaking medical coordinators, and CancerFax provides additional interpreter support throughout the process. For languages other than English, CancerFax arranges professional medical interpreters for critical consultations. Day-to-day communication at the hospital during your stay is managed through the international patient department โ Mandarin fluency is not required.
How long do I need to stay in China for CIK therapy?
For the first treatment cycle, plan for a minimum of 3โ4 weeks in China: 2โ3 days for pre-treatment assessment and blood collection, 14โ21 days for CIK manufacturing, and 3โ5 days for infusions. Some patients extend their stay to complete a second cycle before returning home. Subsequent cycles may be planned as separate shorter trips (10โ14 days each), as manufacturing can sometimes be initiated before arrival if a prior arrangement is made with the centre. CancerFax designs a trip structure based on your specific protocol and logistical constraints.
Can my family member or caregiver accompany me on a medical visa?
Yes. China issues a Medical Attendant Visa for accompanying family members or caregivers โ typically for one companion per patient. The hospital invitation letter should reference the accompanying person. CancerFax arranges for both the patient and companion visa invitation letters to be issued simultaneously by the treating centre.
What happens if my cancer progresses or my condition changes while I am in China?
CancerFax maintains active communication with the treating hospital throughout your stay. If your clinical situation changes, the hospital's oncology team will reassess the treatment plan โ and CancerFax acts as your advocate and liaison throughout. Major Chinese cancer centres are equipped to manage oncological emergencies, including urgent imaging, supportive care, and treatment escalation if required. We also maintain a repatriation assistance contact for situations where returning home early is medically necessary.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Ready to Explore CIK Therapy at a Chinese Cancer Centre?
CancerFax reviews your records, identifies the most appropriate Chinese cancer centre for your case, coordinates eligibility confirmation and cost estimates, and manages the full logistics of your visit โ so you arrive with a confirmed treatment plan, not uncertainty.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.